HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brett Leav Selected Research

2019-nCoV Vaccine mRNA-1273

11/2022Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial.
3/2022Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
1/2022Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.
1/2022Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.
1/2022A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
12/2021Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
11/2021Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
10/2021Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
9/2021Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge.
1/2021Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brett Leav Research Topics

Disease

11COVID-19
11/2022 - 12/2020
4Human Influenza (Influenza)
10/2021 - 01/2018
3Infections
01/2022 - 12/2020
1Severe Acute Respiratory Syndrome
03/2022
1Breakthrough Infections
01/2022
1Headache (Headaches)
12/2021
1Pain (Aches)
12/2021
1Fatigue
12/2021
1Asymptomatic Infections
11/2021
1Fever (Fevers)
01/2021
1Rabies (Hydrophobia)
11/2012

Drug/Important Bio-Agent (IBA)

16VaccinesIBA
11/2022 - 11/2012
102019-nCoV Vaccine mRNA-1273IBA
11/2022 - 01/2021
3Messenger RNA (mRNA)IBA
11/2022 - 01/2021
2Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021 - 01/2018
1mRNA VaccinesIBA
01/2022
1Meningococcal Vaccines (Meningococcal Vaccine)IBA
10/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Lipid NanoparticlesIBA
01/2021
1Monoclonal AntibodiesIBA
11/2012
1Neutralizing AntibodiesIBA
11/2012
1GlobulinsIBA
11/2012
1Immunoglobulin G (IgG)IBA
11/2012
1Rabies Vaccines (Rabies Vaccine)FDA Link
11/2012
1Immunoglobulins (Immunoglobulin)IBA
11/2012

Therapy/Procedure

3Injections
12/2021 - 01/2021
2Intramuscular Injections
11/2021 - 01/2021